SCHEMBL9912188

SCHEMBL9912188

Oc1ccc(CCNc2cc(-c3ccc(-c4cnco4)s3)nc(O)n2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 12/20 0.64
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
PRF1 P14222 1/20 0.33
NPC1 O15118 1/20 0.33
MTOR P42345 1/20 0.33
RAB9A P51151 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32
PRKAG3 Q9UGI9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13895140 0.89 PTGDR (0.60) PTGDRALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL4489823 0.78 PTGDR (1.00) PTGDR
SCHEMBL9912187 0.76 ALDH1A1 (0.44) PTGDRALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL13895136 0.74 PTGDR (0.61) PTGDRALDH1A1SMN1; SMN2ADORA3ADORA2A
SCHEMBL9912208 0.73 PTGDR (0.57) PTGDRALDH1A1SMN1; SMN2ADORA2APIK3CA
SCHEMBL13895057 0.69 PTGDR (0.62) PTGDRALDH1A1SMN1; SMN2
SCHEMBL13895143 0.68 ALDH1A1 (0.55) PTGDRALDH1A1SMN1; SMN2RAB9APRKAB2
SCHEMBL13895056 0.68 ALDH1A1 (0.44) PTGDRALDH1A1SMN1; SMN2
SCHEMBL9912239 0.67 PTGDR (0.63) PTGDRALDH1A1SMN1; SMN2PIK3CAPIK3CB
SCHEMBL13895060 0.67 PTGDR (0.61) PTGDRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193183-B2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists AVENTIS PHARMACEUTICALS INC. (US) 2012-06-05 US disclosed